中国药房2018，Vol.29Issue(6)：725-730,6.DOI:10.6039/j.issn.1001-0408.2018.06.02
药事服务费改革:内涵解析及政策选择
Pharmacy Service Fee Reform:Connotation Analysis and Policy Selection
摘要
Abstract
OBJECTIVE:To provide policy selection for pharmacy service fee reform in China under New Health Reform that drug addition in public hospitals is abolished completely throughout the country. METHODS:The situation and general characteristics of pharmacy service fee reform were summarized since New Health Reform. The multi-dimension of pharmacy service fee was analyzed to define the connotation of pharmacy service fee again. The solution to pharmacy service fee and clinical pharmaceutical care fee reform were put forward. RESULTS:There were many theoretical discussions on the establishment of pharmacy service fee since New Medical Reform,but no achievements had been made in reform practice. The connotation of pharmacy service fee should be subdivided,and the"pharmacy service fee"should be used as the content of the cost compensation for the public service provided by the hospital;"clinical pharmaceutical care fee"should be set up as the cost compensation content of the professional technical service;according to the different natures of the service,the corresponding policy could be designed. CONCLUSIONS:It is suggested that"pharmacy service fee",as lump sum fee,could be solved in the dynamic adjustment of medical service price;"clinical pharmaceutical care fee"should be approved independently and included in the standard charge items according to the individual project.At the same time,local pilot is encouraged,the charge of clinical pharmaceutical care is included in the national charge catalogue,and national standards are studied and formulated. The performance management model of pharmaceutical personnel can be adjusted to promote the healthy development of pharmacy subject.关键词
药学服务/药事服务费/临床药学服务费/新医改/政策Key words
Pharmaceutical care/Pharmacy service fee/Clinical pharmaceutical care fee/New Health Reform/Policy分类
管理科学引用本文复制引用
张静,王虎峰..药事服务费改革:内涵解析及政策选择[J].中国药房,2018,29(6):725-730,6.基金项目
中国人民大学公共管理学院科学研究基金项目(No.2017026) （No.2017026）
